544 results
8-K
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
17 Jun 24
Departure of Directors or Certain Officers
4:02pm
awards under the Restated Plan to all eligible persons other than non-employee members of the Board. However, the Board may also appoint a secondary … other than the Company’s executive officers and non-employee members of the Board. The full Board will administer the Restated Plan with respect
DEFA14A
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
3 Jun 24
Additional proxy soliciting materials
4:03pm
number is well below the normal “cap” suggested by ISS.
3.The restructuring and spin out transactions reduced our total employee headcount to below 40
8-K
EX-3.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
19 Apr 24
Amendments to Articles of Incorporation or Bylaws
4:06pm
. Survival of Rights. The rights conferred on any person by this Bylaw shall continue as to a person who has ceased to be a Director, officer, employee … , and employees or agents, so that any person who is or was a Director, officer, employee or agent of such constituent corporation, or is or was serving
S-8
scfbh0k
1 Mar 24
Registration of securities for employees
4:09pm
8-K
EX-99.1
sbn6q00rvt6jork2
27 Feb 24
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
7:24am
8-K/A
EX-99.1
gnawz qsjagvetc2plv
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
8-K
EX-99.1
wkl8fuh4pj
8 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
4:08pm
8-K
EX-10.1
eixonwu79qz5m
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
8-K
EX-99.1
j0wfw4
8 Aug 23
Ligand Reports Second Quarter 2023 Financial Results
4:02pm
8-K
EX-99.1
kewzm47uv
4 May 23
Ligand Reports First Quarter 2023 Financial Results
4:06pm